Article info
PDFElectronic pages
Correspondence response
eLetter: Tabalumab, an anti-BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an inadequate response to TNF inhibitors by M Genovese
- Correspondence to Dr Athina Pyrpasopoulou, 2nd Prop Department of Internal Medicine, Hippokration GH, Konstantinoupoleos 49, Thessaloniki 54642, Greece; a.pyrpasopoulou{at}doctors.org.uk
Citation
eLetter: Tabalumab, an anti-BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an inadequate response to TNF inhibitors by M Genovese
Publication history
- Received January 7, 2013
- Accepted January 17, 2013
- First published February 9, 2013.
Online issue publication
April 13, 2016
Article Versions
- Previous version (13 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions